Display options
Cite
Chonchol M, Wüthrich RP. Potential future uses of calcimimetics in patients with chronic kidney disease. NDT Plus. 2008;1:i36-i41doi: 10.1093/ndtplus/sfm043.
Chonchol, M., & Wüthrich, R. P. (2008). Potential future uses of calcimimetics in patients with chronic kidney disease. NDT plus, 1i36-i41. https://doi.org/10.1093/ndtplus/sfm043
Chonchol, Michel, and Wüthrich, Rudolf P. "Potential future uses of calcimimetics in patients with chronic kidney disease." NDT plus vol. 1 (2008): i36-i41. doi: https://doi.org/10.1093/ndtplus/sfm043
Chonchol M, Wüthrich RP. Potential future uses of calcimimetics in patients with chronic kidney disease. NDT Plus. 2008 Jan;1:i36-i41. doi: 10.1093/ndtplus/sfm043. PMID: 25983955; PMCID: PMC4421155.
Copy Download .nbib Format: NLM
Share it on

NDT Plus. 2008 Jan;1:i36-i41. doi: 10.1093/ndtplus/sfm043.

Potential future uses of calcimimetics in patients with chronic kidney disease.

NDT plus

Michel Chonchol, Rudolf P Wüthrich

Affiliations

  1. University of Colorado Health Sciences Center , Denver, CO , USA.
  2. Clinic for Nephrology , University Hospital , Zürich , Switzerland.

PMID: 25983955 PMCID: PMC4421155 DOI: 10.1093/ndtplus/sfm043

Abstract

Cinacalcet has proven effective in the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients, and it may also have benefits in stage 3 and 4 chronic kidney disease (CKD). The efficacy of cinacalcet in the treatment of SHPT was investigated in a study of 54 patients with stage 3 and 4 CKD not receiving dialysis. A significant number of these patients achieved at least a 30% reduction in parathyroid hormone (PTH) from baseline with cinacalcet therapy compared with placebo (56% versus 19%; P = 0.006). Another potential use of cinacalcet is in the treatment of persistent hyperparathyroidism (HPT) after kidney transplantation. The pathophysiologic considerations for persistent HPT in patients who have undergone renal transplantation are different from those in stage 3 and 4 CKD. Post-transplant patients with normal graft function often present with hypercalcaemia, low serum phosphorus and persistently elevated levels of PTH. In eight small open-label studies including a total of 83 patients with persistent HPT after successful kidney transplantation, cinacalcet treatment effectively corrected hypercalcaemia and significantly reduced elevated PTH levels. These studies suggest that cinacalcet therapy is an effective therapy in controlling hyperparathyroidism in patients with stage 3 and 4 CKD and in post-transplant patients with persistent hyperparathyroidism.

Keywords: chronic kidney disease; persistent hyperparathyroidism; renal transplant

References

  1. Kidney Int. 2003 Jan;63(1):248-54 - PubMed
  2. Kidney Int. 2005 Feb;67(2):760-71 - PubMed
  3. Nephrol Dial Transplant. 2005 Jul;20(7):1311-4 - PubMed
  4. Transplantation. 2006 Sep 15;82(5):675-80 - PubMed
  5. Am J Kidney Dis. 2005 Jul;46(1):58-67 - PubMed
  6. Kidney Int. 2001 Mar;59(3):1187-201 - PubMed
  7. Nephrol Dial Transplant. 2005 Oct;20(10):2186-93 - PubMed
  8. Q J Med. 1983 Winter;52(205):67-78 - PubMed
  9. Am J Kidney Dis. 2003 Oct;42(4 Suppl 3):S1-201 - PubMed
  10. Kidney Int. 2005 May;67(5):2015-20 - PubMed
  11. J Am Soc Nephrol. 2003 Oct;14 (10 ):2669-76 - PubMed
  12. Transplant Proc. 2005 Apr;37(3):1459-61 - PubMed
  13. Transplant Proc. 1997 Feb-Mar;29(1-2):204-6 - PubMed
  14. J Am Soc Nephrol. 2002 Nov;13(11):2762-9 - PubMed
  15. Nephrol Dial Transplant. 2007 Feb;22(2):577-83 - PubMed
  16. J Am Soc Nephrol. 2005 Mar;16(3):800-7 - PubMed
  17. Nephrol Dial Transplant. 2004 May;19(5):1281-7 - PubMed
  18. Hemodial Int. 2004 Jul 1;8(3):265-72 - PubMed
  19. Nephrol Dial Transplant. 1998 Feb;13(2):436-42 - PubMed
  20. Clin Transplant. 1995 Aug;9(4):277-81 - PubMed
  21. N Engl J Med. 2004 Apr 8;350(15):1516-25 - PubMed
  22. Clin J Am Soc Nephrol. 2006 Mar;1(2):323-6 - PubMed
  23. Am J Transplant. 2006 Oct;6(10):2391-5 - PubMed
  24. Transplant Proc. 2006 Dec;38(10):3514-6 - PubMed
  25. J Am Soc Nephrol. 2005 Feb;16(2):520-8 - PubMed
  26. Arch Intern Med. 2004 Mar 22;164(6):659-63 - PubMed
  27. Nephrol Dial Transplant. 2005 Jul;20(7):1315-9 - PubMed
  28. Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V2-8 - PubMed
  29. Kidney Int Suppl. 2003 Nov;(87):S131-6 - PubMed
  30. N Engl J Med. 2000 May 18;342(20):1478-83 - PubMed
  31. Kidney Int. 2002 Jul;62(1):245-52 - PubMed
  32. J Nephrol. 2004 Mar-Apr;17 (2):190-204 - PubMed
  33. Transplantation. 2007 Mar 15;83(5):546-9 - PubMed
  34. Am J Transplant. 2005 Aug;5(8):1934-41 - PubMed
  35. Nephrol Dial Transplant. 1998;13 Suppl 3:94-7 - PubMed
  36. Clin Nephrol. 2006 May;65(5):374-7 - PubMed
  37. Kidney Blood Press Res. 2004;27(3):191-6 - PubMed
  38. Nephron. 2002 May;91(1):103-11 - PubMed
  39. J Am Soc Nephrol. 2003 Mar;14(3):575-83 - PubMed
  40. Nephrol Dial Transplant. 2007 Feb;22(2):584-91 - PubMed
  41. J Am Soc Nephrol. 2005 Oct;16(10):3092-101 - PubMed
  42. Kidney Int. 1998 Nov;54(5):1704-13 - PubMed
  43. Am J Kidney Dis. 2004 Dec;44(6):1024-30 - PubMed

Publication Types